Zhengye Biotechnology Holding (ZYBT) Raw Materials (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Raw Materials data on file, last reported at $1.1 million in Q4 2025.

• Raw Materials for Q4 2025 came in at $1.1 million, up 8.17% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 million (up 8.17% YoY), and the FY2025 annual result was $1.1 million, up 11.38% from the prior year.
• Raw Materials advanced to $1.1 million in Q4 2025 per ZYBT's latest filing, from $1.0 million in the prior quarter.
• Over five years, Raw Materials peaked at $1.4 million in Q4 2023 and troughed at $1.0 million in Q4 2024.
• A 3-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2024 and 2025: Raw Materials decreased 24.54% in 2024, then increased 8.17% in 2025.
• A 3-year view of Raw Materials shows it stood at $1.4 million in 2023, then declined by 24.54% to $1.0 million in 2024, then climbed by 8.17% to $1.1 million in 2025.
• Business Quant data shows ZYBT's Raw Materials at $1.1 million in Q4 2025, $1.0 million in Q4 2024, and $1.4 million in Q4 2023.